Abiopharma

News list

Director DEWALT DAVID G 🟢 acquired 3.7K shares (1 derivative) of EXELON CORP (EXC) Transaction Date: Apr 28, 2026 | Filing ID: 000007

Full text

News bot April 29, 2026, 8:04 p.m.
🔍 DEWALT DAVID G (Director)

Company: EXELON CORP (EXC)

Report Date: 2026-04-28
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 3,720
Detailed Transactions and Holdings:
- Acquired 3,720 shares of 2026 Directors Restricted Stock Units (Derivative)
  Date: 2026-04-28 | Code: A | Expires: 2027-04-28 | Exercise: 2027-04-28 | equity_swap_involved: 0 | shares_owned_after: 3,720.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest and be settled in shares of Exelon common stock on a 1 for 1 basis. The award will accrue additional stock units through dividend reinvestment which will vest along with the underlying award.